KDM1A and neoplasm: Several recent studies have demonstrated that epigenetic modifiers (SETDB1, LSD1) can regulate tumor cell-intrinsic immunity and T-cell exhaustion [21,22,23]—shedding new light on leveraging the potential of epitherapy to specifically improve the effectiveness of immunotherapies.